Beståndsuppgifter: Outcomes of patients with Hodgkin lymphoma receiving Brentuximab Vedotin (BV) as maintenance therapy after ASCT according to previous exposure to BV. A retrospective analysis of the EBMT Lymphoma Working Party in collaboration with GELTAMO, FIL, LYSA, and Turkish Lymphoma Group

Laddar…

Sparad:

Källa:

Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation. 60(6):879-887

Databas:

Springer Nature Journals